Indoco Remedies gets nod to market generic diabetes drug from USFDA

Indoco Remedies gets nod to market generic diabetes drug from USFDA
Indoco said it plans to produce the medication at its manufacturing facility in Goa. Representational Image: Pixabay

Indoco Remedies on Thursday said it has received approval from the US health regulator to market a generic diabetes medication.

The company has received tentative approval from the US Food and Drug Administration (USFDA) for abbreviated new drug application (ANDA) for Canagliflozin and Metformin Hydrochloride tablets in various strengths, Indoco Remedies said in a regulatory filing.

The company's product is the generic equivalent of Invokamet tablets.

Indoco said it plans to produce the medication at its manufacturing facility in Goa.

Canagliflozin and Metformin Hydrochloride Tablets are used to treat type 2 diabetes mellitus.

"This milestone underscores our commitment to bringing affordable and effective treatment options to patients managing type 2 diabetes," Indoco Remedies MD Aditi Panandikar said.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/personal-finance/news-retirement-corpus-planning-sip-swp-monthly-pension-mutual-fund-investment-calculator-inr-rs-15000-investment-for-25-years-and-152000-income-in-month-for-30-years-tips-strategy-324109

Retirement Planning: SIP+SWP combination; Rs 15,000 monthly SIP for 25 years and then Rs 1,52,000 monthly income for 30 years

https://www.zeebiz.com/personal-finance/news-top-gold-etf-vs-large-cap-mutual-fund-sip-cagr-10-year-return-calculator-which-has-given-higher-return-on-inr-rs-1100000-investment-ntpc-hdfc-bank-aum-nav-324073

Top Gold ETF vs Top Large Cap Mutual Fund 10-year Return Calculator: Which has given higher return on Rs 11 lakh investment; see calculations

https://www.zeebiz.com/personal-finance/news-retirement-planning-corpus-monthly-sip-investment-calculator-40-years-of-age-inr-rs-50000-expenses-what-will-be-retirement-money-inflation-rate-of-return-tips-strategy-324093

Retirement Calculator: 40 years of age, Rs 50,000 monthly expenses; what should be retirement corpus and monthly investment

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-444-day-amrit-vrishti-fd-vs-union-bank-of-india-sumvridhi-333-day-fd-maturity-return-interest-rate-calculator-amount-on-inr-rs-400000-lakh-and-800000-investment-for-general-senior-citizens-324056

SBI 444-day FD vs Union Bank of India 333-day FD: Know maturity amount on Rs 4 lakh and Rs 8 lakh investments for general and senior citizens

https://www.zeebiz.com/personal-finance/news-epfo-vs-sip-vs-ppf-retirement-planning-corpus-interest-rate-maturity-calculator-inr-which-can-create-highest-fund-on-inr-rs-12000-monthly-investment-80c-tax-benefits-mutual-fund-equity-debt-hybrid-324023

EPF vs SIP vs PPF Calculator: Rs 12,000 monthly investment for 30 years; which can create highest retirement corpus

https://www.zeebiz.com/personal-finance/news-home-loan-emi-interest-rate-repayment-vs-mutual-fund-sip-calculator-inr-rs-7000000-home-loan-emi-or-monthly-investment-for-10-years-which-can-be-easier-route-financial-planning-tips-strategy-323832

Home loan EMI vs Mutual Fund SIP Calculator: Rs 70 lakh home loan EMI for 20 years or SIP equal to EMI for 10 years; which can be easier route to buy home; know maths

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-interest-mutual-fund-sip-retirement-corpus-planning-calculator-how-many-years-it-will-take-to-reach-inr-rs-20000000-with-3000-4000-and-5000-monthly-investment-market-linked-return-323948

Power of Compounding: How many years it will take to reach Rs 2 crore corpus if your monthly SIP is Rs 3,000, Rs 4,000, or Rs 5,000

https://www.zeebiz.com/personal-finance/news-new-credit-card-rule-from-november-1-sbi-icici-bank-change-rules-check-details-324078

New Credit Card Rules From November 1: SBI, ICICI Bank change rules - Check details

https://www.zeebiz.com/markets/stocks/news-anil-singhvi-bets-on-stocks-across-banking-chemical-pharma-for-samvat-2081-hdfc-bank-sequent-scientific-abfrl-aarti-industries-epack-durable-324207

Anil Singhvi's 5 stock ideas for Samvat 2081 for stellar gains

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-interest-sip-retirement-corpus-calculator-how-much-fund-can-inr-rs-10000-monthly-investment-generate-in-20-30-40-years-mutual-fund-systematic-investment-plan-324076

Power of Compounding: How much corpus can Rs 10,000 monthly SIP generate in 20, 30, and 40 years

Written By: PTI
Updated: Thu, Jun 06, 2024
04:53 PM IST
New Delhi, PTI
RELATED NEWS
Zydus Lifesciences gets USFDA nod to produce prostrate cancer drug Zydus Lifesciences gets USFDA nod to produce prostrate cancer drug
Alembic Pharma gets US health regulator FDA's nod for scalp psoriasis treatment drug Alembic Pharma gets US health regulator FDA's nod for scalp psoriasis treatment drug
Indoco Remedies gets USFDA nod to market Lofexidine tablets with 180 days exclusivity Indoco Remedies gets USFDA nod to market Lofexidine tablets with 180 days exclusivity

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x